Disclosure Of Effect Of Changes In Foreign Exchange Rates [Text Block]

Innate Pharma - Filing #5981200

Concept	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	As at 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31
Disclosure of effect of changes in foreign exchange rates [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of information when currency is not exchangeable into another currency [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of information when foreign operation’s functional currency is not exchangeable into presentation currency [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of summarised financial information about foreign operation [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of summarised financial information about foreign operation [abstract]
Disclosure of summarised financial information about foreign operation [line items]
Non-current assets	—	—	—	—	25 317 EUR	—	—	—	—	—	—	—	27 175 EUR	—	—	—	—	—
Current assets	—	—	—	—	85 742 EUR	—	—	—	—	—	—	—	148 013 EUR	—	—	—	—	—
Non-current liabilities	—	—	—	—	69 243 EUR	—	—	—	—	—	—	—	83 650 EUR	—	—	—	—	—
Current liabilities	—	—	—	—	32 982 EUR	—	—	—	—	—	—	—	39 636 EUR	—	—	—	—	—
Revenue	—	20 121 EUR	—	—	—	—	—	—	—	—	61 641 EUR	—	—	—	—	—	—	—
Profit (loss) from continuing operations	—	49 471 EUR	—	—	—	—	—	—	—	—	7 570 EUR	—	—	—	—	—	—	—
Profit (loss)	— EUR	49 471 EUR	— EUR	49 471 EUR	—	— EUR	— EUR	— EUR	— EUR	— EUR	7 570 EUR	7 570 EUR	—	— EUR	— EUR	— EUR	— EUR	— EUR
Other comprehensive income	—	468,000 EUR	—	—	—	—	—	—	—	—	670,000 EUR	—	—	—	—	—	—	—
Comprehensive income	— EUR	49 939 EUR	— EUR	49 471 EUR	—	— EUR	— EUR	— EUR	468,000 EUR	— EUR	6 900 EUR	7 570 EUR	—	— EUR	— EUR	994,000 EUR	— EUR	324,000 EUR